Sangrado rectal tras la administración de Dabigatrán.

48-253

Sangrado rectal tras la administración de Dabigatrán.

Rectal bleending after administration of Dabigatran.

P. Díaz De Rada, L. Muñoa, S. De La Riva. HOSPITAL REINA SOFÍA DE TUDELA* Y CLÍNICA UNIVERSIDAD DE NAVARRA**

Recepción:

30/09/2013

Aceptación:

30/09/2013

Publicación:

30/09/2013

Métricas

77

Visualizaciones

Resumen (ES)

We observed rectal bleeding in three asymptomatic patients after administration of Dabigatran in the postoperative period, being this the first manifestation of rectal cancer. In all cases Dabigatran was used as DVT prophylaxis. The cause of bleeding in the three cases was an asymptomatic and previously unknown colo-rectal cancer. All patients underwent tumoral resection surgery. With rectal bleeding in the inmediate postoperatory period after administration of oral anticoagulants, rectal cancer screening must be performed.

Palabras clave (ES):

Anticoagulantes orales

Complicaciones

Dabigatrán

Tromboprofilaxis

Profilaxis antitrombótica

Sangrado rectal

Resumen (EN)

We observed rectal bleeding in three asymptomatic patients after administration of Dabigatran in the postoperative period, being this the first manifestation of rectal cancer. In all cases Dabigatran was used as DVT prophylaxis. The cause of bleeding in the three cases was an asymptomatic and previously unknown colo-rectal cancer. All patients underwent tumoral resection surgery. With rectal bleeding in the inmediate postoperatory period after administration of oral anticoagulants, rectal cancer screening must be performed.

Explorar

Artículos

Volúmenes

Sobre la revista